[1]
|
Callea, F., Favret, M., Marino, C., et al. (1991) Epidemiology of Hepatocellular Carcinoma.
|
[2]
|
Cancer Today: Data Visualization Tools for Exploring the Global Cancer Burden in 2020.
https://gco.iarc.fr/today/home
|
[3]
|
Jemal, A., Murray, T., Samuels, A., et al. (2003) Cancer Statistics, 2003. CA: A Cancer Journal for Clinicians, 53, 5-26. https://doi.org/10.3322/canjclin.53.1.5
|
[4]
|
Yamashita, T. and Kaneko, S. (2016) [Liver Cancer]. Rinsho Byori. The Japanese Journal of Clinical Pathology, 64, 787-796.
|
[5]
|
Tachi, Y., Hirai, T., Miyata, A., et al. (2015) Progressive Fibrosis Significantly Correlates with Hepatocellular Carcinoma in Patients with a Sustained Virological Response. Hepatology Research, 45, 238-246.
https://doi.org/10.1111/hepr.12331
|
[6]
|
Bataller, R. and Brenner, D.A. (2005) Liver Fibrosis. Journal of Clinical Investigation, 115, 209-218.
https://doi.org/10.1172/JCI24282
|
[7]
|
Gressner, A.M. and Weiskirchen, R. (2006) Modern Pathogenetic Concepts of Liver Fibrosis Suggest Stellate Cells and TGF-Beta as Major Players and Therapeutic Targets. Journal of Cellular and Molecular Medicine, 10, 76-99.
https://doi.org/10.1111/j.1582-4934.2006.tb00292.x
|
[8]
|
Friedman, S.L. (1993) Seminars in Medicine of the Beth Israel Hospital Boston. The Cellular Basis of Hepatic Fibrosis. Mechanisms and Treatment Strategies. The New England Journal of Medicine, 328, 1828-1835.
https://doi.org/10.1056/NEJM199306243282508
|
[9]
|
Friedman, S.L., Maher, J.J. and Bissell, D.M. (2000) Mechanisms and Therapy of Hepatic Fibrosis: Report of the AASLD Single Topic Basic Research Conference. Hepa-tology, 32, 1403-1408.
https://doi.org/10.1053/jhep.2000.20243
|
[10]
|
Ikeda, N., Murata, S., Maruyama, T., et al. (2012) Platelet-Derived Adenosine 5’-Triphosphate Suppresses Activation of Human Hepatic Stellate Cell: In Vitro Study. Hepatology Research, 42, 91-102.
https://doi.org/10.1111/j.1872-034X.2011.00893.x
|
[11]
|
Murata, S., Hashimoto, I., Nakano, Y., Myronovych, A., Watanabe, M. and Ohkohchi, N. (2008) Single Administration of Thrombopoietin Prevents Progression of Liver Fibrosis and Promotes Liver Regeneration after Partial Hepatectomy in Cirrhotic Rats. Annals of Surgery, 248, 821-828. https://doi.org/10.1097/SLA.0b013e31818584c7
|
[12]
|
Watanabe, M., Murata, S., Hashimoto, I., et al. (2009) Plate-lets Contribute to the Reduction of Liver Fibrosis in Mice. Journal of Gastroenterology and Hepatology, 24, 78-89. https://doi.org/10.1111/j.1440-1746.2008.05497.x
|
[13]
|
Aryal, B., Yamakuchi, M., Shimizu, T., et al. (2018) Deci-phering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology, 2018, Article ID: 9142672. https://doi.org/10.1155/2018/9142672
|
[14]
|
Huang, P., Xu, X., Wang, L., et al. (2014) The Role of EGF-EGFR Signalling Pathway in Hepatocellular Carcinoma Inflamma-tory Microenvironment. Journal of Cellular and Molecular Medicine, 18, 218-230.
https://doi.org/10.1111/jcmm.12153
|
[15]
|
D’Alessandro, R., Refolo, M.G., Lippolis, C., et al. (2014) Antagonism of Sorafenib and Regorafenib Actions by Platelet Factors in Hepatocellular Carcinoma Cell Lines. BMC Cancer, 14, Ar-ticle No. 351.
https://doi.org/10.1186/1471-2407-14-351
|
[16]
|
Badawy, A.A., El-Hindawi, A., Hammam, O., et al. (2015) Impact of Epidermal Growth Factor Receptor and Transforming Growth Factor-α on Hepatitis C Virus-Induced Hepatocarcino-genesis. APMIS, 123, 823-831.
https://doi.org/10.1111/apm.12431
|
[17]
|
Fuchs, B.C., Hoshida, Y., Fujii, T., et al. (2014) Epidermal Growth Factor Receptor Inhibition Attenuates Liver Fibrosis and Development of Hepatocellular Carcinoma. Hepatology, 59, 1577-1590. https://doi.org/10.1002/hep.26898
|
[18]
|
Chen, B., Liu, J., Wang, X., et al. (2018) Co-Expression of PDGF-B and VEGFR-3 Strongly Correlates with Poor Prognosis in Hepatocellular Carcinoma Patients after Hepatectomy. Clinics and Research in Hepatology and Gastroenterology, 42, 126-133. https://doi.org/10.1016/j.clinre.2016.11.006
|
[19]
|
Zhan, P., Qian, Q. and Yu, L.K. (2013) Serum VEGF Level Is Associated with the Outcome of Patients with Hepatocellular Carcinoma: A Meta-Analysis. Hepatobiliary Surgery and Nutrition, 2, 209-215.
|
[20]
|
Takagi, S., Sato, S., Oh-Hara, T., et al. (2013) Platelets Promote Tumor Growth and Metas-tasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2. PLOS ONE, 8, E73609. https://doi.org/10.1371/journal.pone.0073609
|
[21]
|
Leslie, M. (2010) Cell Biology: Beyond Clotting: The Powers of Platelets. Science, 328, 562-564.
https://doi.org/10.1126/science.328.5978.562
|
[22]
|
Bihari, C., Rastogi, A., Shasthry, S.M., et al. (2016) Platelets Contribute to Growth and Metastasis in Hepatocellular Carcinoma. APMIS, 124, 776-786. https://doi.org/10.1111/apm.12574
|
[23]
|
Morimoto, Y., Nouso, K., Wada, N., et al. (2014) Involvement of Platelets in Extrahepatic Metastasis of Hepatocellular Carcinoma. Hepatology Research, 44, E353-E359. https://doi.org/10.1111/hepr.12315
|
[24]
|
Lee, C.-H., Lin, Y.-J., Lin, C.-C., et al. (2015) Pretreatment Platelet Count Early Predicts Extrahepatic Metastasis of Human Hepatoma. Liver International, 35, 2327-2336. https://doi.org/10.1111/liv.12817
|
[25]
|
Gasic, G.J., Gasic, T.B. and Stewart, C.C. (1968) Antimetastatic Effects Associated with Platelet Reduction. Proceedings of the National Academy of Sciences of the United States of America, 61, 46-52.
https://doi.org/10.1073/pnas.61.1.46
|
[26]
|
Nakamura, T., Nawa, K. and Ichihara, A. (1984) Partial Purification and Characterization of Hepatocyte Growth Factor from Serum of Hepatectomized Rats. Biochemical and Biophysical Re-search Communications, 122, 1450-1459.
https://doi.org/10.1016/0006-291X(84)91253-1
|
[27]
|
Nakamura, T. (1987) Platelet-Derived Growth Regulators and Mechanism of Liver Regeneration. Tanpakushitsu Kakusan Koso, 32, 1113-1125.
|
[28]
|
Matsuo, R., Nakano, Y., Ohkohchi, N. (2011) Platelet Administration via the Portal Vein Promotes Liver Regeneration in Rats after 70% Hepa-tectomy. Annals of Surgery, 253, 759-763. https://doi.org/10.1097/SLA.0b013e318211caf8
|
[29]
|
Myronovych, A., Murata, S., Chiba, M., et al. (2010) Role of Platelets on Liver Regeneration after 90% Hepatectomy in Mice. Journal of Hepatology, 49, 363-372. https://doi.org/10.1016/j.jhep.2008.04.019
|
[30]
|
Lopez, M., Kieling, C., Uribe Cruz, C., et al. (2013) Platelet Increases Survival in A Model of 90% Hepatectomy in Rats. Liver International, 34, 1049-1056. https://doi.org/10.1111/liv.12326
|
[31]
|
Padickakudy, R., Pereyra, D., Offensperger, F., et al. (2017) Bivalent Role of Intra-Platelet Serotonin in Liver Regeneration and Tumor Recurrence in Humans. Journal of Hepatology, 67, 1243-1252.
https://doi.org/10.1016/j.jhep.2017.08.009
|
[32]
|
Lesurtel, M., Raptis, D.A., Melloul, E., et al. (2014) Low Platelet Counts after Liver Transplantation Predict Early Posttransplant Survival: The 60-5 Criterion. Liver Transplantation, 20, 147-155. https://doi.org/10.1002/lt.23759
|
[33]
|
Alkozai, E.M., Nijsten, M.W., De, Jong, K.P., et al. (2010) Imme-diate Postoperative Low Platelet Count Is Associated with Delayed Liver Function Recovery after Partial Liver Resection. Annals of Surgery, 251, 300-306.
https://doi.org/10.1097/SLA.0b013e3181b76557
|
[34]
|
Lai, Q., Castro Santa, E., Rico Juri, J.M., et al. (2014) Neu-trophil and Platelet-to-Lymphocyte Ratio as New Predictors of Dropout and Recurrence after Liver Transplantation for Hepatocellular Cancer. Transplant International, 27, 32-41.
https://doi.org/10.1111/tri.12191
|
[35]
|
Xia, W., Ke, Q., Guo, H., et al. (2017) Expansion of the Milan Criteria without Any Sacrifice: Combination of the Hangzhou Criteria with the Pre-Transplant Platelet-to-Lymphocyte Ratio. BMC Cancer, 17, Article No. 14.
https://doi.org/10.1186/s12885-016-3028-0
|
[36]
|
Sahasrabuddhe, V.V., Gunja, M.Z., Graubard, B.I., et al. (2012) Nonsteroidal Anti-Inflammatory Drug Use, Chronic Liver Disease and Hepatocellular Carcinoma. JNCI: Journal of the National Cancer Institute, 104, 1808-1814.
https://doi.org/10.1093/jnci/djs452
|
[37]
|
Vlachogiannakos, J., et al. (2013) Hepatocellular Carcinoma in Chronic Hepatitis B Patients under Antiviral Therapy. World Journal of Gastroenterology, 19, 8822-8830. https://doi.org/10.3748/wjg.v19.i47.8822
|
[38]
|
Lee, P.C., Yeh, C.M., Hu, Y.W., et al. (2016) Antiplatelet Therapy Is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection. Annals of Surgical Oncology, 23, 874-883. https://doi.org/10.1245/s10434-016-5520-9
|
[39]
|
Li, J.H., Wang, Y., Xie, X.Y., et al. (2016) Aspirin in Combination with TACE in Treatment of Unresectable HCC: A Matched-Pairs Analysis. American Journal of Cancer Research, 6, 2109-2116.
|
[40]
|
Boas, F.E., Brown, K.T., Ziv, E., et al. (2019) Aspirin Is Associated with Improved Liver Function after Embolization of Hepatocellular Carcinoma. AJR American Journal of Roentgenology, 213, 1-7.
https://doi.org/10.2214/AJR.18.20846
|
[41]
|
Tao, Y.Q. (2018) Nonsteroidal Anti-Inflammatory Drugs Especially Aspirin Are Linked to Lower Risk and Better Survival of Hepatocellular Carcinoma: A Meta-Analysis. Cancer Man-agement & Research, 10, 2695-2709.
https://doi.org/10.2147/CMAR.S167560
|
[42]
|
Li, X., Yu, Y. and Liu, L. (2021) Influence of Aspirin Use on Clini-cal Outcomes of Patients with Hepatocellular Carcinoma: A Meta-Analysis. Clinics and Research in Hepatology and Gastroenterology, 45, Article ID: 101545.
https://doi.org/10.1016/j.clinre.2020.09.006
|